<DOC>
	<DOCNO>NCT00144209</DOCNO>
	<brief_summary>The primary objective study determine pramipexole ( Sifrol ) 0.25 mg 0.75 mg daily inferior levodopa 100 mg 300 mg ( combination benserazide 25mg 75mg = Madopar DR ) daily treatment patient idiopathic restless legs syndrome fulfil International Diagnostic Criteria . The efficacy parameter include objective measure leg movement time spend bed , quantitative clinical assessment severity RLS , form RLS-score . In addition , efficacy evaluation aim compare impact pramipexole levodopa outcome measure quality life sleep .</brief_summary>
	<brief_title>Assess Efficacy Safety Dopamine Agonist Pramipexole Versus Levodopa / Benserazide ( MadoparÂ® DR ) Patients With Restless Legs Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Benserazide</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Dopamine Agonists</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Benserazide , levodopa drug combination</mesh_term>
	<criteria>Inclusion criterion : Patients diagnose idiopathic restless legs syndrome fulfilling International Diagnostic Criteria 1 . Male female patient , age 25 85 year . Patients present RLS symptom almost every day , judge investigator 5 PLM/h bedtime three screen actigraphy night . Patients must give write informed consent accordance ICHGCP local legislation prior participation study . Exclusion criterion : Patients significant disease restless legs syndrome exclude . A significant disease define disease , opinion investigator may put patient risk participation study , may influence result study patient 's ability participate expect relevantly reduce life expectancy . Patients know hypersensitivity contraindication pramipexole , levodopa benserazide substance present study medication . Patients irondeficiency Patients disability incapacity preclude regular attendance clinic study visit , patient shiftworkschedule otherwise unable follow regular sleepwake cycle . Patients previously treat pramipexole levodopa . Pregnant nursing woman woman childbearing age risk pregnancy willing use adequate contraceptive method ( hormonal contraception intrauterine device ) study period .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>